Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Depreciation & Amortization (CF) (2021 - 2025)

Medicinova (MNOV) has disclosed Depreciation & Amortization (CF) for 7 consecutive years, with $4199.0 as the latest value for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) changed N/A to $4199.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $9376.0, a N/A change, with the full-year FY2025 number at $20099.0, down 4.64% from a year prior.
  • Depreciation & Amortization (CF) was $4199.0 for Q4 2025 at Medicinova, down from $5177.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $7168.0 in Q3 2021 to a low of $4105.0 in Q1 2023.
  • A 5-year average of $5439.2 and a median of $5360.0 in 2024 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): plummeted 31.37% in 2022, then surged 30.33% in 2024.
  • Medicinova's Depreciation & Amortization (CF) stood at $6374.0 in 2021, then tumbled by 30.51% to $4429.0 in 2022, then rose by 24.0% to $5492.0 in 2023, then decreased by 5.68% to $5180.0 in 2024, then decreased by 18.94% to $4199.0 in 2025.
  • Per Business Quant, the three most recent readings for MNOV's Depreciation & Amortization (CF) are $4199.0 (Q4 2025), $5177.0 (Q1 2025), and $5180.0 (Q3 2024).